Maxime M A Verhoeven (Maxime Ma Verhoeven)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 8

Top Topics

Optical Coherence Tomography

Systemic Lupus Erythematosus

Rheumatoid Arthritis

Top Venues

The Journal of rheumatology

Arthritis care & research

Journal of personalized medicine

Rheumatology advances in practice

This page only lists publications with an associated author ORCID identifier.

Publications

Johannes W G Jacobs, Maxime M A Verhoeven, Paco M J Welsing
Unravelling the Cost of Biological Strategies in Rheumatoid Arthritis: A Kaleidoscope of Methodologies, Interpretations, and Interests. The Journal of rheumatology 48 (12) (2021)
Maxime M A Verhoeven, Antonius A A Westgeest, Andreas Schwarting, Johannes W G Jacobs, Caroline Heller, Jacob M van Laar, Floris P J G Lafeber, Janneke Tekstra, Konstantinos Triantafyllias, Paco M J Welsing
Development and validation of rheumatoid arthritis disease activity indices including HandScan (optical spectral transmission) scores. Arthritis care & research (2021)
Maxime M A Verhoeven, Antonius A A Westgeest, Johannes W G Jacobs
A Sex Difference in HandScan Scores in Rheumatoid Arthritis Patients and Controls? An Ongoing Analysis of the Sex Difference and Other Potential Confounders. The Journal of rheumatology 48 (6) (2021)
Helen R Gosselt, Maxime M A Verhoeven, Maja Bulatović-Ćalasan, Paco M Welsing, Maurits C F J de Rotte, Johanna M W Hazes, Floris P J G Lafeber, Mark Hoogendoorn, Robert de Jonge
Complex Machine-Learning Algorithms and Multivariable Logistic Regression on Par in the Prediction of Insufficient Clinical Response to Methotrexate in Rheumatoid Arthritis. Journal of personalized medicine 11 (1) (2021)
Maxime M A Verhoeven, Janneke Tekstra, Anne C A Marijnissen, Anna J L Meier, Antonius A A Westgeest, Floris P J G Lafeber, Johannes W G Jacobs, Jacob M van Laar, Paco M J Welsing
Utility of the HandScan in monitoring disease activity and prediction of clinical response in rheumatoid arthritis patients: an explorative study. Rheumatology advances in practice 5 (1) (2021)
Maxime M A Verhoeven, Janneke Tekstra, Jacob M van Laar, Attila Pethö-Schramm, Michelle E A Borm, Johannes W J Bijlsma, Johannes W G Jacobs, Floris P J G Lafeber, Paco M J Welsing
Effect on Costs and Quality-adjusted Life-years of Treat-to-target Treatment Strategies Initiating Methotrexate, or Tocilizumab, or Their Combination in Early Rheumatoid Arthritis. The Journal of rheumatology 48 (4) (2020)
Maxime M A Verhoeven, Janneke Tekstra, Johannes W G Jacobs, Johannes W J Bijlsma, Jacob M van Laar, Attila Pethö-Schramm, Michelle E A Borm, Floris P J Lafeber, Paco M J Welsing
Is tocilizumab monotherapy as effective in preventing radiographic progression in rheumatoid arthritis as its combination with methotrexate? Arthritis care & research (2020)
Maxime M A Verhoeven, Marjolein Jh de Hair, Janneke Tekstra, Johannes Wj Bijlsma, Jacob M van Laar, Attila Pethoe-Schramm, Michelle Ea Borm, Evert-Jan Ter Borg, Suzanne P Linn-Rasker, Xavier M Teitsma, Floris Pjg Lafeber, Johannes Wg Jacobs, Paco Mj Welsing
Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials. Annals of the rheumatic diseases 78 (10) (2019)